Open-Label, Multicentre, One Year Extension of the Evaluation of the Safety of Donepezil Hcl in Patients With Dementia Associated With Cerebrovascular Disease.
Phase of Trial: Phase III
Latest Information Update: 10 Sep 2009
At a glance
- Drugs Donepezil (Primary)
- Indications Dementia
- Focus Adverse reactions
- 09 Jan 2009 Actual end date (Aug 2005) added as reported by ClinicalTrials.gov.
- 09 Jan 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2005 New trial record.